Cardiol Therapeutics
CRDL | NASDAQ
$0.98
-$0.02 (-2.00%)
At close: Nov 16, 2026, 4:00 PM ET
$0.99
+$0.01 (+1.43%)
After-hours:
Nov 16, 2026, 6:56 PM ET
Cardiol Therapeutics Company Profile
Company profile explainedCompany Profile
Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. Furthermore, the company is developing a subcutaneous version of CardiolRx, aimed at addressing the cardiac fibrosis and inflammation linked to the onset and progression of heart failure. Cardiol Therapeutics Inc. was established in 2017 and operates from its headquarters in Oakville, Canada.
Key Executives
| Name | Position |
|---|---|
| David G. Elsley | President, Chief Executive Officer & Director |
| Bernard Lim | Chief Operating Officer |
| Christopher J. Waddick | Chief Financial Officer, Corporate Secretary & Director |
| Andrew Warwick Hamer | Chief Medical Officer and Head of Research & Development |
| John A. Geddes BSCPT | Vice President of Corporate Development |
| Trevor Burns | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 23, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Sep 23, 2026 | 6-K | Filing |
| Sep 16, 2026 | SUPPL | Filing |
| Sep 16, 2026 | F-10/A | [Amend] Filing |
| Sep 16, 2026 | 6-K | Filing |
| Sep 15, 2026 | 6-K | Filing |
| Sep 11, 2026 | 6-K | Filing |
| Sep 10, 2026 | 6-K | Filing |
| Sep 10, 2026 | F-X | Filing |
| Sep 10, 2026 | F-10 | Filing |
Cardiol Therapeutics
| Country | Canada |
| IPO Date | Jan 15, 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 18 |
| CEO | David G. Elsley |
Contact Details
2265 Upper Middle Road East Oakville,
ON L6H 0G5 Canada
Stock Details
| Ticker Symbol | CRDL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001702123 |
| CUSIP Number | 14161Y200 |
| ISIN Number | CA14161Y2006 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove CRDL